<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-09-08">8 September 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Martin</forename><surname>Digweed</surname></persName>
							<email>martin.digweed@charite.de</email>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bastian</forename><surname>Salewsky</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gabriele</forename><surname>Hildebrand</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susanne</forename><surname>Rothe</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ann</forename><forename type="middle">Christin</forename><surname>Parplys</surname></persName>
							<affiliation key="aff2">
								<orgName type="laboratory">Laboratory of Radiobiology and Experimental Radiation Oncology</orgName>
								<orgName type="institution">University Medical Center Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Janina</forename><surname>Radszewski</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Moritz</forename><surname>Kieslich</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><surname>Wessendorf</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Harald</forename><surname>Krenzlin</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kerstin</forename><surname>Borgmann</surname></persName>
							<affiliation key="aff2">
								<orgName type="laboratory">Laboratory of Radiobiology and Experimental Radiation Oncology</orgName>
								<orgName type="institution">University Medical Center Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">André</forename><surname>Nussenzweig</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">Laboratory of Genome Integrity</orgName>
								<orgName type="institution">National Cancer Institute</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">National Institute of Health</orgName>
								<address>
									<settlement>Besthesda</settlement>
									<region>Maryland</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karl</forename><surname>Sperling</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-09-08">8 September 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">F1BDEDA0777816CDBDC49804DBE184D8</idno>
					<idno type="DOI">10.1038/mt.2015.144</idno>
					<note type="submission">Received 1 June 2015; accepted 5 August 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:47+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Over 90% of patients with Nijmegen breakage syndrome (NBS), a hereditary cancer disorder, are homoallelic for a 5 bp deletion in the NBN gene involved in the cellular response to DNA damage.</s><s>This hypomorphic mutation leads to a carboxy-terminal protein fragment, p70-nibrin, with some residual function.</s><s>Average age at malignancy, typically lymphoma, is 9.7 years.</s><s>NBS patients are hypersensitive to chemotherapeutic and radiotherapeutic treatments, thus prevention of cancer development is of particular importance.</s><s>Expression of an internally deleted NBN protein, p80-nibrin, has been previously shown to be associated with a milder cellular phenotype and absence of cancer in a 62-year-old NBS patient.</s><s>Here we show that cells from this patient, unlike other NBS patients, have DNA replication and origin firing rates comparable to control cells.</s><s>We used here antisense oligonucleotides to enforce alternative splicing in NBS patient cells and efficiently generate the same internally deleted p80-nibrin protein.</s><s>Injecting the same antisense sequences as morpholino oligomers (VivoMorpholinos) into the tail vein of a humanized NBS murine mouse model also led to efficient alternative splicing in vivo.</s><s>Thus, proof of principle for the use of antisense oligonucleotides as a potential cancer prophylaxis has been demonstrated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Patients with the rare autosomal recessive Nijmegen breakage syndrome (NBS; MIM 251260) are characterized by microcephaly and growth retardation, life threatening, however, is an immunodeficiency and, particularly, a greatly increased cancer risk.</s><s>Malignancy develops before the age of 20 in over 40% of patients. <ref type="bibr" target="#b0">1</ref></s><s>World wide prevalence is estimated at 1:100,000 live births, however, NBS is particularly common in Eastern Europe with carrier frequencies as high as 1:155 in some populations.</s><s>No specific treatment is available for NBS patients beyond γ-globulin replacement therapy.</s><s>Indeed, treatment of malignancy in NBS is particularly difficult since the underlying gene, NBN (nibrin), is involved in the cellular response to DNA damage. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref></s><s>The consequent hypersensitivity of NBS patients severely limits therapeutic options and standard chemotherapeutics such as cyclophosphamide must be used at lower doses and radiotherapy completely avoided. <ref type="bibr" target="#b3">4</ref></s><s>Tackling the cause of increased malignancy is thus an important objective for clinical management of NBS and other hereditary cancer syndromes, such as Ataxia telangiectasia and Fanconi anemia, with similar defects in DNA damage recognition and repair.</s></p><p><s>The vast majority of NBS patients are homozygous for a founder mutation, a five base pair deletion in exon 6 of the NBN gene (c.657_661del5,</s><s>p.K219fsX19).</s><s>This is in fact a hypomorphic mutation which leads to a truncated 26 kD amino-terminal protein and, importantly, a 70 kD carboxy-terminal protein due to alternative translation from a cryptic start site upstream of the deletion. <ref type="bibr" target="#b4">5</ref></s><s>Null mutation of Nbn in the mouse is embryonically lethal <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7</ref> but mice in vivo and murine cells in vitro can be rescued by ectopic expression of the 70 kD carboxy-terminal nibrin protein. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref></s><s>Other rarer NBN mutations are also associated with the translation of truncated nibrin proteins. <ref type="bibr" target="#b9">10</ref></s><s>Obviously, these protein fragments retain sufficient functionality to ensure survival.</s><s>NBN has been connected to many cellular functions: DNA double strand break repair, cell cycle checkpoint activation, telomere maintenance, meiotic recombination, and immunoglobulin isotope switching.</s><s>In all of these roles, nibrin is involved as part of a complex with the ATPase and DNA binding protein RAD50 and the nuclease MRE11 (ref.</s><s>3).</s></p><p><s>Nibrin binds to MRE11 via its carboxy terminal region, and indeed, p70-nibrin also binds MRE11.</s><s>It is the same region of nibrin which interacts with ATM to activate the DNA damage response in terms of checkpoint regulation. <ref type="bibr" target="#b10">11</ref></s><s>It is not unreasonable to conclude that survival of NBS homozygotes is attributable to the maintenance of these carboxy-terminal protein-protein interactions whilst their immunodeficiency and malignancy can be ascribed to the lack of protein-protein interactions of the amino terminal region.</s><s>3]<ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref> Cells expressing only the truncated 26 kD nibrin fragment, containing the FHA and first BRCT domain, are nonviable. <ref type="bibr" target="#b5">6</ref></s><s>edian age at diagnosis of malignancy in NBS is 9.5 years. 4</s><s>However, one unique NBS patient, RR, is now 62 years of age and has never developed a malignancy. <ref type="bibr" target="#b15">16</ref></s><s>She is the oldest NBS patient known.</s><s>Unlike other NBS patients, this patient has a two base insertion in the vicinity of an exonic splice enhancer in exon 7 of the NBN gene. <ref type="bibr" target="#b16">17</ref></s><s>As a consequence, alternative splicing occurs and an mRNA lacking both exon 6 and exon 7 is produced and translated to a protein of 80 kDa which contains both the carboxy-terminal and the amino-terminal protein interaction domains.</s><s>We speculate that this p80-nibrin contributes to RR's milder phenotype and indeed, this protein variant did improve survival of null mutant murine cells in vitro. <ref type="bibr" target="#b16">17</ref></s><s>ince the founder mutation which the majority of NBS patients carry is located in exon 6, directed alternative splicing to remove exons 6 and 7 and generate p80-nibrin could be the basis of an anticancer prophylaxis for NBS patients.</s><s>Splicing can be manipulated in cells by introducing antisense oligouncleotides which mask critical sequences. <ref type="bibr" target="#b18">18,</ref><ref type="bibr" target="#b19">19</ref></s><s>1]<ref type="bibr" target="#b22">[22]</ref> Here we have used antisense oligonucleotides to enforce alternative splicing in NBS cells in vitro and a humanized NBS mouse model in vivo.</s><s>Our results demonstrate proof of principle for antisense oligonucleotide directed alternative splicing in NBS.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>DNA replication in cell lines expressing p95-nibrin, p80-nibrin, or p70-nibrin Figure <ref type="figure" target="#fig_0">1a</ref> shows the exon structure of the NBN gene and the protein and protein fragments derived from it.</s><s>In Figure <ref type="figure" target="#fig_0">1b</ref>, the three major nibrin proteins are shown in a western blot: p95-nibrin, p80-nibrin, and p70-nibrin.</s><s>p95-nibrin is the full-length product of the wild-type gene.</s><s>In cells from patients homozygous for the major founder mutation, c.657_661del5, p.K219fsX19, alternative translation leads to a carboxy-terminal product, p70-nibrin. <ref type="bibr" target="#b4">5</ref></s><s>In the patient RR with the homozygous mutation c.742-743insGG, alternative splicing leads to exon skipping and translation of p80-nibrin. <ref type="bibr" target="#b16">17</ref></s><s>This protein lacks sequences from exon 6 and 7 but does carry both amino terminal and carboxy terminal domains, unlike p70-nibrin which lacks the amino terminal BRCT and FHA domains.</s></p><p><s>Since in addition to DNA repair, nibrin is also involved in DNA replication, <ref type="bibr" target="#b23">23,</ref><ref type="bibr" target="#b24">24</ref> we examined DNA replication origin firing and elongation rates in cells from NBS patients, including RR, using the DNA fiber assay.</s><s>Cells were incubated sequentially in medium</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Directed exon-skipping in vitro</head><p><s>Since the c.657_661del5 founder mutation is located in exon 6, the same alternative splicing observed in cells from patient RR would also effectively remove that mutation, suggesting a potential prophylactic treatment to reduce DNA replication errors and, hopefully, cancer occurrence.</s><s>In order to force alternative splicing in NBS patient cells, we searched for exonic splicing enhancers in exons 6 and 7 as targets for oligonucleotide binding.</s><s>Using the web-based ESEfinder, <ref type="bibr" target="#b25">25,</ref><ref type="bibr" target="#b26">26</ref> a cluster of binding sites for splicing factors was found between positions c.636 and c.650 in exon 6 with motif scores between 2.53 and 4.45.</s><s>In exon 7, there are Oligonucleotides with the same sequences in sense orientation (SON) were synthesized as controls.</s><s>AON were transfected into control and NBS patient cells using a cationic liposome reagent and RNA was isolated over a period of 7 days.</s><s>RT-PCR using primers in sequences derived from exons 5 and 10 was used to detect full length and alternatively spliced NBN mRNA: a 579 bp product is derived from the full-length mRNA; the mRNA lacking exons 6 and 7 yields a PCR product of 267 bp.</s><s>As shown in Figure <ref type="figure">4a</ref>, alternative splicing was induced rapidly and efficiently in both control and NBS patient fibroblasts.</s><s>The shorter product was sequenced to confirm its origin (Figure <ref type="figure">4b</ref>).</s><s>Already 24 hours after transfection, the fulllength mRNA is fully replaced by the mRNA lacking exons 6 and 7. Four days after transfection full-length mRNA begins to return but even after 7 days a significant amount of alternatively spliced mRNA is still formed.</s><s>Transfection of the individual antisense oligonucleotides led to mRNA lacking exon 6 or exon 7, respectively (data not shown).</s><s>Since these mRNAs have frameshifts, they are lost during abortive translation due to nonsense-mediated decay.</s></p><p><s>Examining the NBS patient cells transfected with both antisense oligonucleotides for nibrin protein showed a kinetic compatible with the expression of alternatively spliced mRNA after AON transfection (Figure <ref type="figure">4c</ref>).</s><s>At 24 hours after transfection, a considerable amount of p80-nibrin, the product of the mRNA lacking exons 6 and 7, is present although residual p70-nibrin is still detectable.</s><s>Six days later, p80-nibrin is still found although the major NBN product is once again p70-nibrin.</s><s>In control cells, p95-nibrin levels were hardly affected and p80-nibrin was not detected (data not shown).</s><s>We have previously reported on the considerable stability of p95-nibrin, <ref type="bibr" target="#b27">27,</ref><ref type="bibr" target="#b28">28</ref> even removing its mRNA for 4 days seems not to significantly alter its abundance.</s></p><p><s>We examined the kinetics of AON directed exon splicing up to 24 hours in more detail.</s><s>As shown in Figure <ref type="figure">5</ref>, while SON had no effect on nibrin translation, AON again lead to loss of p70-nibrin and production of p80-nibrin.</s><s>Using MRE11 as an internal control, we estimated that p80-nibrin production was actually at a maximum 15 hours after AON transfection, while degradation of p70-nibrin lead to p80-nibrin being the major nibrin protein at 24 hours after transfection (Figure <ref type="figure">5b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Directed exon-skipping in vivo</head><p><s>For experiments in vivo, we exploited the humanized NBS mouse which expresses the major human mutant NBN allele on a null murine background. <ref type="bibr" target="#b8">9</ref></s><s>For transfer, the antisense ESE sequences were synthesized as Vivo-Morpholinos which are specifically designed for in vivo animal studies in which laboratory transfection reagents are inappropriate. <ref type="bibr" target="#b29">29</ref></s><s>Vivo-Morpholinos were first Vivo-Morpholinos were injected into the tail vein of eight mice daily for 4 days before analysis of NBN transcripts by RT-PCR.</s><s>As shown in Figure <ref type="figure" target="#fig_5">7a</ref> for one treated mouse and one control mouse injected in parallel with an identical volume of sodium chloride solution, the RT-PCR product from the alternatively spliced mRNA was readily detected in several organs.</s><s>The semiquantitative analysis for all eight mice shown in Figure <ref type="figure" target="#fig_5">7b</ref> indicates the efficiency of directed exon skipping in the organs analyzed.</s><s>In the kidney, the alternatively spliced mRNA lacking exons 6 and 7 is practically the only mRNA detected.</s><s>Targeting is also very efficient in muscle and liver.</s><s>The alternatively spliced mRNA is also formed in the hematological tissues relevant for NBS.</s><s>In contrast, targeting efficiency in the brain and gonads was extremely low.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Even though the patient RR had a milder clinical course, at the cellular level there were few differences in DNA repair assays to cells from patients with common c.657_661del5 mutation. <ref type="bibr" target="#b16">17</ref></s><s>owever, as we have recently reported, base mutations occurring during replication probably play a larger role in tumorigenesis in NBS than exogenous DNA damage. <ref type="bibr" target="#b30">30</ref></s><s>Indeed, it is becoming clear that a large proportion of cancer risk in general can be attributed to replication errors rather than environmental challenges. <ref type="bibr" target="#b31">31</ref></s><s>A role for nibrin in DNA replication and the resolution of replication intermediates has been clearly demonstrated earlier. <ref type="bibr" target="#b23">23,</ref><ref type="bibr" target="#b24">24</ref></s><s>Thus DNA replication seemed to be a more pertinent end point to examine in cells expressing p80-nibrin.</s><s>In NBS cells expressing the major founder mutation, elongation rates were lower than in control cells, presumably due to replication fork stalling when replication intermediates are inefficiently resolved.</s><s>The replication problem at activated forks is reported to result in the firing of further dormant origins <ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref><ref type="bibr" target="#b34">[34]</ref> and this is exactly what we observe in these cells.</s><s>Cells from patient RR which express p80-nibrin had DNA replication characteristics indistinguishable from control cells.</s><s>This possibly reflects the fact that p80-nibrin, unlike p70-nibrin, contains the amino-terminal domains which have been shown to interact with transcription factor E2F at DNA replication origins. <ref type="bibr" target="#b12">13</ref></s><s>However, our attempts to demonstrate a direct interaction between p80nibrin and E2F were unsuccessful, probably due to the extremely low expression level of p80-nibrin (Figure <ref type="figure" target="#fig_0">1b</ref>).</s></p><p><s>Treatment of lymphoma in NBS is particularly challenging since the DNA damage response is impaired in patient cells leading to extreme sensitivity to standard therapeutic measures. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b35">35</ref></s><s>Thus any treatment which reduces the likelihood of developing a tumor in the first place would be particularly beneficial.</s><s>Restoration of wild type NBN by gene therapy would be one approach fraught, however, with the problems of vector delivery and regulated gene expression encountered in other diseases.</s><s>Alternatively, oligonucleotide based therapeutics are possibly more amenable.</s><s>Among these, antisense oligonucleotides are probably most advanced.</s><s>1]<ref type="bibr" target="#b22">[22]</ref> The strategy employed for muscular dystrophy was forced alternative splicing of a mutated mRNA so that rather than a truncated dystrophin, a molecule with an internal deletion but intact amino and carboxy termini is translated.</s><s>Since these domains interact, respectively, with the cytoskeleton and the plasma membrane, the functional superiority of the molecule generated is understandable.</s><s>Interestingly, the starting point for the development of this strategy was the original observation that in individual patients with severe truncating dystrophin mutations, low level alternative splicing leads to the production of some functional dystrophin. <ref type="bibr" target="#b38">38</ref></s><s>he data presented in this report on NBS are comparable to the situation in Duchenne muscular dystrophy described above.</s><s>A single, malignancy free NBS patient with an alternatively spliced mRNA produces a nibrin protein with an internal deletion but intact amino and carboxy termini.</s><s>We show here that this protein corrects the aberrant DNA replication characteristics of NBS cells.</s><s>Using antisense oligonucleotides to mask exonic splice enhancers we can direct alternative splicing in cells in vitro and a murine NBS model in vivo.</s><s>The extent of alternative splicing varied in various organs, basically as previously observed for directed splicing in the β-globin gene by others. <ref type="bibr" target="#b29">29</ref></s><s>The level of p80-nibrin expression is low even in lymphoblastoid cells from the patient RR, suggesting that the low levels seen in the treated mice might have a significant effect.</s><s>Further experiments must follow this proof of principle study, which examine p80-nibrin protein expression in humanized mice after AON treatment, correction of the cellular phenotype in terms of DNA replication rates and, particularly, tumor incidence.</s></p><p><s>One possible advantage in comparison to the situation in Duchenne muscular dystrophy is the fact that it is not terminally differentiated cells that are the therapy target.</s><s>Furthermore, rather than correction of a severe disease symptom such as ambulation, the aim here would be purely prophylactic.</s><s>A somewhat comparable situation is given by the recently published use of antisense oligonucleotides to successfully reduce factor XI and thus prevent venous thrombosis. <ref type="bibr" target="#b39">39</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head><p><s>Cell culture and oligonucleotide transfection.</s><s>The immortalized human NBS cell lines GM7166VA7 homozygous for NBN c.657_661del5, RR homozygous for NBN c.742-743insGG and a control cell line, LN9SV, transformed with simian virus 40 (SV40) were cultured in Dulbecco's modified Eagle's medium (Life Technologies, Carlsbad, CA) supplemented with 5% glucose and 10% fetal calf serum strictly in the absence of antibiotics.</s><s>Cell culture conditions were 37 °C and 5% CO 2 .</s><s>Spontaneous transformed murine fibroblasts were grown from ear explants of the humanized Nbn -/-NBN del5 mouse 9 under the conditions described above.</s><s>Synthetic antisense oligonucleotides (Biomers, Ulm, Germany) were applied to exponentially growing cells at 33 nmol/l in the presence of 1.7 µg/ml Lipofectamine 2000 (Life Technologies, Darmstadt, Germany) according to the manufacturer's instructions.</s><s>Antisense oligonucleotide sequences were 5′-CUUUCCUGCCGUCCUGACAGAUCAA-3′ complementary to positions c.629-c.653 in exon 6 and 5′-ACAGUCAGGAAUUAAGGUC UGUGAG-3′ complementary to positions c.831-c.855 in exon 7.</s><s>As controls, oligonucleotides representing the target sequences were used: 5′-UUGAUCUGUCAGGACGGCAGGAAAG-3′ (exon 6) and 5′-CUCA CAGACCUUAAUUCCUGACUGU-3′ (exon 7).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Vivo-Morpholino treatment of humanized mice in vivo.</head><p><s>Vivo-Morpholinos were synthesized by Gene Tools (Philomath, OR) using the same sequences used for the antisense oligonucleotides.</s><s>Vivo-Morpholinos have an octa-guanidine dendrimer for penetration of the cell membrane and are stabilized by morpholine rings and phosphoramidate bonds. <ref type="bibr" target="#b29">29</ref></s><s>Humanized NBS Mice, Nbn -/-NBN del5 , were injected in the lateral tail vein daily for 4 days.</s><s>The first injection of vivo-morpholinos was at 12 µg/g body weight, the following three injections were at 6 µg/g body weight.</s><s>Control mice with identical genotypes were injected with 0.9% sodium chloride.</s><s>Mice were killed 24 hours after final injection and organs removed for analysis.</s><s>Animal studies were approved by the Landesamt für Gesundheit und Soziales, Berlin (G0438/09).</s><s>Immunoprecipitates were washed four times with lysis buffer and proteins were eluted from the beads by boiling for 5 minutes.</s><s>Lysates and immunoprecipitates were electrophoresed using the NuPage system (Life Technologies) in 4-12% Bis-Tris polyacrylamide gradient gels.</s><s>Following electrophoresis, proteins were transferred to Invitrolon PVDF membranes (Life Technologies).</s><s>Membranes were blocked for at least 1 hour in 10% nonfat milk in Tris-buffered saline, pH 7.6, with 0.1% Tween-20 (TBS-T).</s><s>Incubation with primary and secondary antibodies was performed in 5% nonfat milk in TBS-T.</s><s>All washing steps were carried out using TBS-T.</s><s>Immunoblots were probed with monoclonal antibody directed against full-length nibrin (Novus Biologicals) or monoclonal antibody directed against amino acids 182-582 of MRE11 (Novus Biologicals).</s><s>Primary antibodies were detected with horseradish peroxidase-conjugated goat anti-rabbit IgG or goat anti-mouse IgG (BD Pharmingen, San Diego, CA).</s><s>Chemiluminescence was developed using Western Lightning (PerkinElmer Life Sciences, Boston, MA).</s></p><p><s>DNA fiber assay.</s><s>Fibroblasts were labeled with 25 μmol/l CldU (Sigma-Aldrich, St. Louis, MO) followed by 250 μmol/l IdU (Sigma-Aldrich) each for 45 minutes.</s><s>Labeled cells were harvested and DNA fiber spreads prepared on microscope glass slides as described. <ref type="bibr" target="#b40">40</ref></s><s>Fibers were first acid treated and then were stained with monoclonal rat anti-BrdU (AbD Serotec, Oxford, UK) followed by monoclonal mouse anti-BrdU (Becton Dickinson, Franklin, NJ).</s><s>As previously described, <ref type="bibr" target="#b41">41</ref> fibers were visualized with fluorescent secondary antibodies: goat anti-rat Alexa Fluor 555 and goat anti-mouse Alexa Fluor 488 (Molecular Probes, Eugene, OR).</s><s>Fibers were examined with the Axioplan 2 (Zeiss, Jena, Germany) fluorescence microscope.</s><s>Different types of tracks were classified: ongoing replication, stalled forks, terminated forks, first pulse origins, second pulse origins.</s><s>Lengths of CldU and IdU tracks were measured using ImageJ software on images captured with the Axioplan 2 microscope including a standard 20 µm scale bar.</s><s>Micrometer lengths were converted into kilobases and replication rates derived from the length of the labeling period.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 The</head><label>1</label><figDesc><div><p><s>Figure 1 The NBN gene and nibrin variants.</s><s>(a) The exon structure of the gene is shown with the site of the major mutation in Nijmegen breakage syndrome patients.</s><s>The full-length nibrin protein, with an apparent molecular weight of 95 kDa and the two protein fragments of 26 and 70 kDa arising from the c.657_661del5 (p.K219fsX19) mutation, and the 80 kDa protein found in patient RR with the mutation c.742_743insGG leading to excision of exons 6 and 7 from the NBN mRNA are shown.</s><s>The locations of serine residues targeted by the ATM kinase and acetylated lysine residues are indicated as are the relative locations of the FHA, BRCT, Mre11-binding and ATM-interaction domains.</s><s>(b) The blot shows the immunoprecipitation of p95-nibrin, p80-nibrin and p70-nibrin from the indicated SV40 immortalized cells: LN9SV (NBN +/+ ; 2 × 10 6 cells); RR (homozygous for NBN c.742-743insGG; 1 × 10 7 cells); GM7166VA7 (homozygous for NBN c.657_661del5; 5 × 10 6 cells).</s><s>Immunoprecipitation with a polyclonal antibody directed to amino acids 395-742 of nibrin; western blot with a monoclonal antibody directed against full-length nibrin.</s><s>Due to extreme expression differences short and long exposures of the filter are shown.</s></p></div></figDesc><graphic coords="2,85.34,389.20,249.14,252.38" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>containing</head><label></label><figDesc><div><p><s>CldU or IdU to allow detection of (i) replication forks originating during labeling (either during the first CldU or the second IdU pulse), (ii) forks already fired before labeling, (iii) forks terminating during labeling, or (iv) forks stalled during labeling.</s><s>The relative amounts of these different replication figures give insight into the replicative status of the examined cells.</s><s>As shown in Figure2a, 17.4% of replication figures in control cells were first pulse origins, while in cells homozygous for c.657_661del5 and expressing p70-nibrin, first pulse origins made up 46.4% of replication figures.</s><s>Cells heterozygous for c.657_661del5 and, importantly, cells from patient RR, with the homozygous mutation c.742-743insGG and expressing p80-nibrin, have proportions of first pulse origins comparable to the control cells.</s><s>In agreement, as shown in Figure2b, replication rates are significantly lower in cells expressing p70-nibrin than in control cells or cells expressing p80-nibrin (P &lt; 2e−06, Mann-Whitney test).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2 DNA replication characteristics in Nijmegen breakage syndrome cells with c.657_661del5 or c.742_743insGG NBN mutations.</s><s>(a) Control fibroblasts, fibroblasts homozygous or heterozygous for NBN c.657_661del5 and fibroblasts from patient RR homozygous for NBN c.742_743insGG were examined with the DNA fiber assay.</s><s>The graph shows the proportion of first pulse origins in the unchallenged fibroblast cultures.</s><s>The data are the average and SE for at least 150 replication forks from each of three samples.</s><s>(b) The distribution of replication fork rates is shown for the cells examined in Figure 2a.</s><s>The data are the average and standard deviation for at least 100 replication forks from each of three samples.</s></p></div></figDesc><graphic coords="3,296.80,254.11,189.26,395.78" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 Figure 4</head><label>34</label><figDesc><div><p><s>Figure 3 Exonic splice enhancers in NBN.</s><s>The sequences of NBN exon 6 and exon 7 are shown together with the positions of sequences to which the splicing factors SRp40, SF2/ASF, and SC35 potentially bind.</s><s>The NBN sequences identified as likely exonic splice enhancers are indicated.</s></p></div></figDesc><graphic coords="4,49.86,71.09,235.34,249.38" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 Figure 6 Molecular</head><label>56</label><figDesc><div><p><s>Figure 5 Kinetics of directed alternative mRNA splicing.</s><s>(a) The immunoblot shows the immunprecipitation of p70-nibrin and p80-nibrin isolated at the given times from Nijmegen breakage syndrome patient cells transfected with sense orientation or antisense oligonucleotides.</s><s>IP and WB as described for Figure 4c.</s><s>(b) The graphic shows the relative amounts of p70-nibrin and p80-nibrin normalized to the amount of MRE11 as an internal control.</s><s>The data are the average and standard deviation of three independent experiments.</s></p></div></figDesc><graphic coords="5,90.56,103.88,171.02,273.74" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 7</head><label>7</label><figDesc><div><p><s>Figure 7 Directed alternative mRNA splicing in vivo.</s><s>(a) The gel shows the RT-PCR products using primers to detect full-length mRNA and mRNA lacking exons 6 and 7. Top: mRNA isolated from a humanized Nijmegen breakage syndrome mouse injected over 4 days with V-MO.</s><s>Bottom: mRNA from a control mouse injected with NaCl.</s><s>(b) Organs from 8 V-MO treated humanized mice were assessed for alternative splicing by RT-PCR as in Figure 7a and densitometry of gel photos.</s><s>The data give the average and standard deviation for the relative amount of alternatively spliced NBN mRNA in the organs of the eight mice.</s></p></div></figDesc><graphic coords="6,79.08,105.45,200.54,292.94" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>RT-PCR to detect alternative mRNA splicing</head><label></label><figDesc><div><p><s>. RNA was extracted from cells or tissues according to standard procedures (Trizol) and treated with DNaseI to remove contaminating genomic DNA.</s><s>For the first-strand cDNA synthesis, 2 µg RNA of each sample, MMLV reverse transcriptase and random hexamer primers were used.</s><s>The subsequent RT-PCR reaction used 2 µl of the cDNA product and specific NBN primers: Exon 5.F Exon 10.R producing a 579 bp product from full length nibrin mRNA and a product of 267 bp from mRNA lacking exons 6 and 7 due to alternative splicing.</s><s>PCR products were examined on agarose gels.</s><s>Gels were scanned for measurement of band intensity and semiquantitative determination of transcript amounts.</s><s>NaCl, 5 mmol/l EDTA, and 0.3% Triton X-100 containing a protease inhibitor mixture (Roche Applied Science, Penzberg, Germany).</s><s>Lysates were immunoprecipitated with polyclonal antibody directed to amino acids 395-742 of nibrin (Novus Biologicals, Littleton, CO) or polyclonal antibody directed to full-length MRE11 (Novus Biologicals) and Dynabeads Protein G (Life Technologies) for 3 hours.</s></p></div></figDesc><table><row><cell>Immunoprecipitation and western blot. Immunoprecipitates were</cell></row><row><cell>prepared by lysing transfected cells in 50 mmol/l Tris-HCl pH 7.5,</cell></row><row><cell>150 mmol/l</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">© The American Society of Gene &amp; Cell Therapy Directed Splicing in Nijmegen Breakage Syndrome</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.moleculartherapy.org vol. 24 no. 1 jan. 2016 © The American Society of Gene &amp; Cell Therapy Directed Splicing in Nijmegen Breakage Syndrome</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.moleculartherapy.org vol. 24 no. 1 jan. 2016</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>The authors are grateful to the animal facility of the Charité for mouse breeding and care.</s><s>This work was supported by the Deutsche Krebshilfe (grant number 108864 to M.D.).</s><s>The authors declare that no conflict of interest exists.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Nijmegen breakage syndrome (NBS)</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chrzanowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gregorek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dembowska-Bagińska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">,</forename><surname>Kalina</surname></persName>
		</author>
		<author>
			<persName><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Digweed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Orphanet J Rare Dis</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">13</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome</title>
		<author>
			<persName><forename type="first">R</forename><surname>Varon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vissinga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Platzer</surname></persName>
		</author>
		<author>
			<persName><surname>Cerosaletti</surname></persName>
		</author>
		<author>
			<persName><surname>Km</surname></persName>
		</author>
		<author>
			<persName><surname>Chrzanowska</surname></persName>
		</author>
		<author>
			<persName><surname>Kh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Saar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="467" to="476" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Carney</surname></persName>
		</author>
		<author>
			<persName><surname>Maser</surname></persName>
		</author>
		<author>
			<persName><surname>Rs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Olivares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Beau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yates</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="477" to="486" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS)</title>
		<author>
			<persName><forename type="first">B</forename><surname>Dembowska-Baginska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Perek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brozyna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wakulinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Olczak-Kowalczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gladkowska-Dura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Blood Cancer</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="186" to="190" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Maser</surname></persName>
		</author>
		<author>
			<persName><surname>Zinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Petrini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="417" to="421" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Dumon-Jones</surname></persName>
		</author>
		<author>
			<persName><surname>Frappart</surname></persName>
		</author>
		<author>
			<persName><surname>Po</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sajithlal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hulla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schmid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="7263" to="7269" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><surname>Tessarollo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nussenzweig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="105" to="109" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability</title>
		<author>
			<persName><forename type="first">I</forename><surname>Demuth</surname></persName>
		</author>
		<author>
			<persName><surname>Frappart</surname></persName>
		</author>
		<author>
			<persName><surname>Po</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hildebrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Melchers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lobitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stöckl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2385" to="2397" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models</title>
		<author>
			<persName><forename type="first">S</forename><surname>Difilippantonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Celeste</forename></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fernandez-Capetillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Reina</forename><forename type="middle">San</forename><surname>Ht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Van</forename><surname>Laethem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Cell Biol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="675" to="685" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Chromosome instability and nibrin protein variants in NBS heterozygotes</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tanzanella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Antoccia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Spadoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Masi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pecile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Demori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="297" to="303" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Active role for nibrin in the kinetics of atm activation</title>
		<author>
			<persName><forename type="first">K</forename><surname>Cerosaletti</surname></persName>
		</author>
		<author>
			<persName><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Concannon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1691" to="1699" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sakamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Morishima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matsuura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Biol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1846" to="1851" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Maser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">K</forename><surname>Mirzoeva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Olivares</surname></persName>
		</author>
		<author>
			<persName><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><surname>Br</surname></persName>
		</author>
		<author>
			<persName><surname>Zinkel</surname></persName>
		</author>
		<author>
			<persName><surname>Ra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="6006" to="6016" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin</title>
		<author>
			<persName><forename type="first">C</forename><surname>Spycher</surname></persName>
		</author>
		<author>
			<persName><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><surname>Es</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pavic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Morrice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Janscak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="227" to="240" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA doublestrand break processing and repair</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><surname>Dodson</surname></persName>
		</author>
		<author>
			<persName><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Limbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Guenther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="87" to="99" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">A new chromosome instability disorder</title>
		<author>
			<persName><forename type="first">P</forename><surname>Maraschio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Peretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lambiase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lo</forename><surname>Curto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Caufin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gargantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Genet</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="353" to="365" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">R</forename><surname>Varon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Dutrannoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Weikert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tanzarella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Antoccia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stöckl</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Mild Nijmegen breakage syndrome phenotype due to alternative splicing</title>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="679" to="689" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Efficient in vivo manipulation of alternative pre-mRNA splicing events using antisense morpholinos in mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Parra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><surname>Mohandas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Conboy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="6033" to="6039" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Antisense-mediated exon skipping: Taking advantage of a trick from Mother Nature to treat rare genetic diseases</title>
		<author>
			<persName><forename type="first">M</forename><surname>Veltrop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aartsma-Rus</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">4827</biblScope>
			<biblScope unit="page" from="46" to="49" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kinali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Arechavala-Gomeza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cirak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Adkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="918" to="928" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Eteplirsen for the treatment of Duchenne muscular dystrophy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><surname>Rodino-Klapac</surname></persName>
		</author>
		<author>
			<persName><surname>Lr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Roush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bird</surname></persName>
		</author>
		<author>
			<persName><surname>Lowes</surname></persName>
		</author>
		<author>
			<persName><surname>Lp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eteplirsen Study Group</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="637" to="647" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Ann Neurol</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study</title>
		<author>
			<persName><forename type="first">T</forename><surname>Voit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Topaloglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Straub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Muntoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Deconinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Campion</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="987" to="996" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The essential function of the MRN complex in the resolution of endogenous replication intermediates</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bruhn</surname></persName>
		</author>
		<author>
			<persName><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ai</forename><surname>Zw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Q</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="182" to="195" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">SV40 T antigen interacts with Nbs1 to disrupt DNA replication control</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Avni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1305" to="1316" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">ESEfinder: A web resource to identify exonic splicing enhancers</title>
		<author>
			<persName><forename type="first">L</forename><surname>Cartegni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Krainer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="3568" to="3571" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><surname>Chew</surname></persName>
		</author>
		<author>
			<persName><surname>Sl</surname></persName>
		</author>
		<author>
			<persName><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Krainer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="2490" to="2508" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Krüger</surname></persName>
		</author>
		<author>
			<persName><surname>Chrzanowska</surname></persName>
		</author>
		<author>
			<persName><surname>Kh</surname></persName>
		</author>
		<author>
			<persName><surname>Seemanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Digweed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene</title>
		<imprint>
			<biblScope unit="volume">447</biblScope>
			<biblScope unit="page" from="12" to="17" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Nijmegen breakage syndrome: the clearance pathway for mutant nibrin protein is allele specific</title>
		<author>
			<persName><forename type="first">B</forename><surname>Salewsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wessendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><surname>Krenzlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Digweed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene</title>
		<imprint>
			<biblScope unit="volume">519</biblScope>
			<biblScope unit="page" from="217" to="221" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Morcos</surname></persName>
		</author>
		<author>
			<persName><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biotechniques</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="613" to="614" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Deficiency of the DNA repair protein nibrin increases the basal but not the radiation induced mutation frequency in vivo</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wessendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vijg</surname></persName>
		</author>
		<author>
			<persName><surname>Nussenzweig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Digweed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutat Res</title>
		<imprint>
			<biblScope unit="volume">769</biblScope>
			<biblScope unit="page" from="11" to="16" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tomasetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vogelstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page" from="78" to="81" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Replication fork movement sets chromatin loop size and origin choice in mammalian cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Courbet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Arnoult</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wronka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Anglana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Brison</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">455</biblScope>
			<biblScope unit="page" from="557" to="560" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Q</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">,</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><surname>Da</surname></persName>
		</author>
		<author>
			<persName><surname>Blow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="3331" to="3341" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Heterozygous mutations in PALB2 cause DNA replication and damage response defects</title>
		<author>
			<persName><forename type="first">J</forename><surname>Nikkilä</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Parplys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pylkäs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Borgmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2578</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Fatal toxicity following radio-and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome</title>
		<author>
			<persName><forename type="first">L</forename><surname>Distel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Neubauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Varon</surname></persName>
		</author>
		<author>
			<persName><surname>Holter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grabenbauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Pediatr Oncol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="44" to="48" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">A</forename><surname>Pramono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Takeshima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Alimsardjono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Matsuo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">226</biblScope>
			<biblScope unit="page" from="445" to="449" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Wilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lloyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Carville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Honeyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agrawal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="330" to="338" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The &quot;rescue&quot; of dystrophin synthesis in boys with Duchenne muscular dystrophy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Nicholson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="525" to="531" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Factor XI antisense oligonucleotide for prevention of venous thrombosis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Büller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bethune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bhanot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gailani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">,</forename><surname>Monia</surname></persName>
		</author>
		<author>
			<persName><surname>Bp</surname></persName>
		</author>
		<author>
			<persName><surname>Raskob</surname></persName>
		</author>
		<author>
			<persName><surname>Ge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">FXI-ASO TKA Investigators</title>
				<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="232" to="240" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase</title>
		<author>
			<persName><forename type="first">E</forename><surname>Petermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maya-Mendoza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zachos</surname></persName>
		</author>
		<author>
			<persName><surname>Gillespie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jackson</forename><surname>Da</surname></persName>
		</author>
		<author>
			<persName><surname>Caldecott</surname></persName>
		</author>
		<author>
			<persName><surname>Kw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="3319" to="3326" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">DNA damage by X-rays and their impact on replication processes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Parplys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Petermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><surname>Dikomey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Borgmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiother Oncol</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="466" to="471" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
